Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Chinese adults with chronic rhinosinusitis with nasal polyps is starting tezepelumab to evaluate nasal polyp symptoms; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: NOT_YET_RECRUITING